Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
about
Hallmarks of cancer and AU-rich elementsmiR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway.Dysregulation of TTP and HuR plays an important role in cancers.Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma.IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.The role of RNA-binding protein tristetraprolin in cancer and immunity.Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients.Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1.
P2860
Q26744134-EE6F07D9-0C73-44FD-8E54-2CBA0E477ABBQ37688919-7216F774-249E-42DE-95D7-F7DBC84760CFQ38958552-78546088-D190-495F-B8C4-A8A6B1FDC122Q39102545-35F3961C-4BED-4E9E-BCFC-7751EDDE8CAEQ41972983-6E4BF99F-B6F1-4588-9E26-EA54048CD703Q47417882-64968ACB-48BA-4D76-9319-BE8CC5837544Q51070624-460E21E1-4E3E-4DA4-8DC5-D1FF317E8662Q55408888-FF1807E9-C37F-4CC1-ACF2-39945FD7F603
P2860
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
@en
type
label
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
@en
prefLabel
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
@en
P2093
P2860
P356
P1433
P1476
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
@en
P2093
Jiazeng Xia
Kaiyuan Deng
Yigang Chen
P2860
P2888
P356
10.1038/SREP24505
P407
P577
2016-04-14T00:00:00Z
P6179
1053129376